2020 news
The Biomaterials and Tissue Engineering Group (BiTEG) 22nd annual meeting was hosted by the University of Leeds as an online event on Thursday 17 December 2020.
Researchers from the Universities of York and Melbourne have shed new light on how viruses like hepatitis B, dengue and SARS-CoV-2 hijack a cell paving the way for potential anti-viral drugs to stop the virus in its tracks.
The Department of Biology's Dr Katherine Bridge has just been awarded the Kay Kendall Leukaemia Fund Intermediate Fellowship for her research, one of only two recipients this year.
A team of scientists - including an academic from the University of York - has been awarded more than £8m (9.1m euros) for a major research programme into how enzymes work on complex sugars.
Pioneering research at the University of York could help us understand how the latest new antibiotics against tuberculosis (TB) work - and pave the way for improved treatments in the future.
A drug used to treat cirrhosis of the liver may be an effective treatment for a form of Dementia and motorneuron disease, scientists have discovered.
Researchers at York are to explore new advances in human blood stem cell research with partners in Japan and Cambridge.
UK Scientists are launching a major new project to answer key questions on how the immune system interacts with COVID-19, in order to develop better treatments, diagnostics and vaccines.
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
Researchers are using laser-light technology to develop handheld biosensors with the potential to deliver fast, real-time blood test results for patients including those suffering from COVID-19 with secondary infections such as pneumonia.
Researchers at York have discovered a new mechanism which is used by cells of the immune system to control the strength of our response to infections.
Research from the Department of Chemistry in York is providing vital insights into the novel Coronavirus SARS-CoV-2, and may help underpin antibody tests and future therapies.
A team from the University of York have produced a protein which stores and protects the genome of the SARS-CoV-2 virus, which causes COVID-19, paving the way to possible antiviral therapies.
A piece of high-tech equipment used for the diagnosis of COVID-19 has been loaned to York Hospital by the University of York.
Steve Johnson is co-investigator on a new BBSRC (Biotechnology and Biological Sciences Research Council) Tools and Technology grant.
New research has deciphered how rogue communications in blood stem cells can cause Leukaemia.
York hosted the 21st annual 'Work in Progress Meeting' of the White Rose Biomaterials and Tissue Engineering Group on 16 December.